Voyage
Pet parentsVets
DispatchJoinGet free access

Veterinary Clinical Reference

Look up any drug or condition.

Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.

/
306 evergreen hubsCited at every claimContinuously updatedFree for verified vets
All (306)Pain & Osteoarthritis (9)Dermatology & Allergy (14)Cardiology (5)Respiratory & Emergency (6)Neurology & Epilepsy (14)Endocrinology (7)GI & Appetite (18)Infectious Disease (5)Nephrology & Urology (4)Ophthalmology (7)Behavior (12)Immunology & Oncology (3)Toxicology & Emergency (23)Exotic & Zoological (164)
All species (5)Canine (3)Feline (2)
FelineJul 3, 2026

Feline Hypertrophic Cardiomyopathy: ACVIM Staging, Diagnosis, and Evidence-Based Management

A clinician-facing evidence hub on feline HCM: ACVIM 2020 staging, echocardiographic diagnosis, clopidogrel-based thromboprophylaxis with the FAT CAT trial and its 2024 absolute-benefit re-analysis, acute FATE management, and emerging myosin-inhibitor and rapamycin therapies.

Read →
FelineJun 8, 2026

Rapamycin (Sirolimus) for Feline Hypertrophic Cardiomyopathy: RAPACAT Trial, Evidence, and Safety

The RAPACAT RCT showed low-dose delayed-release rapamycin significantly reduced LV wall-thickness progression in subclinical feline HCM at Day 180 (P=0.01), with mechanistic and ex vivo platelet-safety data now folded into one evergreen clinical reference.

Read →

Voyage surfaces cited veterinary evidence to inform your clinical judgment — never to replace it. Always confirm dosing and treatment against current formularies.

Built for pets. Not repurposed from humans.

Built by Voyage